EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access

Racial comparisons in treatment of rectal adenocarcinoma and survival in the military health system

Yvonne L Eaglehouse iD, Sarah Darmon, Michele M Gage, Craig D Shriver iD, Kangmin Zhu

JNCI Cancer Spectrum · 2024

DOI: 10.1093/jncics/pkae074 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift JNCI Cancer Spectrum, 2024. Verfasst von Yvonne L Eaglehouse und 4 weiteren Autor:innen. Beteiligte Einrichtung: Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA. Hauptthemen laut MEDLINE: Adenocarcinoma, Black or African American, Healthcare Disparities, Neoplasm Recurrence, Local. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 67 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Department of Surgery, Uniformed Services University of the Health Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Racial disparities in treatment and outcomes of rectal cancer have been attributed to patients’ differential access to care. We aimed to study treatment and outcomes of rectal cancer in the equal access Military Health System (MHS) to better understand potential racial disparities.

Methods

We accessed the MilCanEpi database to study a cohort of patients aged 18 and older who were diagnosed with rectal adenocarcinoma between 1998 and 2014. Receipt of guideline recommended treatment per tumor stage, cancer recurrence, and all-cause death were compared between non-Hispanic White and Black patients using multivariable regression models with associations expressed as odds (AORs) or hazard ratios (AHRs) and their 95% confidence intervals (CIs).

Results

The study included 171 Black and 845 White patients with rectal adenocarcinoma. Overall, there were no differences in receipt of guideline concordant treatment (AOR = 0.76, 95% CI = 0.45 to 1.29), recurrence (AHR = 1.34, 95% CI = 0.85 to 2.12), or survival (AHR = 1.08, 95% CI = 0.77 to 1.54) for Black patients compared with White patients. However, Black patients younger than 50 years of age at diagnosis (AOR = 0.34, 95% CI = 0.13 to 0.90) or with stage III or IV tumors (AOR = 0.28, 95% CI = 0.12 to 0.64) were less likely to receive guideline recommended treatment than White patients in stratified analysis.

Conclusions

In the equal access MHS, although there were no overall racial disparities in rectal cancer treatment or clinical outcomes between Black and White patients, disparities among those with early-onset or late-stage rectal cancers were noted. This suggests that factors other than access to care may play a role in the observed disparities and warrants further research.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AdenocarcinomaBlack or African AmericanHealthcare DisparitiesNeoplasm Recurrence, LocalRectal NeoplasmsAdultAgedFemaleHumansMaleMiddle AgedCause of DeathGuideline AdherenceHealth Services AccessibilityMilitary Health ServicesNeoplasm StagingOdds RatioPractice Guidelines as TopicProportional Hazards ModelsUnited StatesWhite

Autor:innen und Institutionen

  • Murtha Cancer Center Research Program, Department of Surgery, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
  • The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., Bethesda, MD, USA.
  • Department of Surgery, Division of Surgical Oncology, Walter Reed National Military Medical Center, Bethesda, MD, USA.
  • Department of Preventive Medicine & Biostatistics, F. Edward Hébert School of Medicine, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.

ORCID-Profile: Yvonne L Eaglehouse, Craig D Shriver

Förderung

  • Department of Surgery, Uniformed Services University of the Health Sciences

Zitieren

APA

Eaglehouse, Y. L., Darmon, S., Gage, M. M., Shriver, C. D., & Zhu, K. (2024). Racial comparisons in treatment of rectal adenocarcinoma and survival in the military health system. JNCI Cancer Spectrum. https://doi.org/10.1093/jncics/pkae074

Vancouver

Eaglehouse YL, Darmon S, Gage MM, Shriver CD, Zhu K. Racial comparisons in treatment of rectal adenocarcinoma and survival in the military health system. JNCI Cancer Spectrum. 2024. doi:10.1093/jncics/pkae074

BibTeX
@article{Eaglehouse2024,
  author = {Eaglehouse, Yvonne L and Darmon, Sarah and Gage, Michele M and Shriver, Craig D and Zhu, Kangmin},
  title = {Racial comparisons in treatment of rectal adenocarcinoma and survival in the military health system},
  journal = {JNCI Cancer Spectrum},
  year = {2024},
  doi = {10.1093/jncics/pkae074}
}
Kostenlos starten →